Denosumab Treatment in CKD Patients at High Risk of Fracture
NCT05692297
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
102
Enrollment
OTHER
Sponsor class
Conditions
Chronic Kidney Diseases
Fracture
Bone Density, Low
End Stage Renal Disease
Interventions
DRUG:
Denosumab
DRUG:
Non-denosumab
Sponsor
Capital Medical University